Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

This publication has 21 references indexed in Scilit:

• Biology and disease associations of Epstein–Barr virus
  Philosophical Transactions Of The Royal Society B-Biological Sciences, 2001
• Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated Diseases
  Annual Review of Microbiology, 2000
• Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation
  The Lancet, 1999
• Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)
  Springer Seminars in Immunopathology, 1998
• Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue
  Clinical and Experimental Immunology, 1996
• Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
  The Lancet, 1995
• Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
  The Journal of Experimental Medicine, 1993
• Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
  Science, 1992
• Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia
  Science, 1985
• Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virus
  International Journal of Cancer, 1968